These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 8853062)
1. Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia. Gaylord MS; Smith ZL; Lorch V; Blank ML; Snyder F Am J Med Sci; 1996 Oct; 312(4):149-54. PubMed ID: 8853062 [TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia. Jehle R; Schlame M; Büttner C; Frey B; Sinha P; Rüstow B Biochim Biophys Acta; 2001 May; 1532(1-2):60-6. PubMed ID: 11420174 [TBL] [Abstract][Full Text] [Related]
3. Altered platelet activating factor metabolism in insulin dependent diabetes mellitus. Memon RA; Saeed SA; Jabbar A; Jafri A; Gilani AH; Saleem S; Akbani H J Pak Med Assoc; 1995 May; 45(5):122-5. PubMed ID: 7563575 [TBL] [Abstract][Full Text] [Related]
4. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. Stafforini DM; McIntyre TM; Carter ME; Prescott SM J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727 [TBL] [Abstract][Full Text] [Related]
5. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. Satoh K; Imaizumi T; Kawamura Y; Yoshida H; Takamatsu S; Mizono S; Shoji B; Takamatsu M Prostaglandins; 1988 May; 35(5):685-98. PubMed ID: 3399678 [TBL] [Abstract][Full Text] [Related]
6. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum. Ostermann G; Kostner GM; Gries A; Malle E; Till U Haemostasis; 1989; 19(3):160-8. PubMed ID: 2744632 [TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor acetylhydrolase in human seminal plasma. Letendre ED; Miron P; Roberts KD; Langlais J Fertil Steril; 1992 Jan; 57(1):193-8. PubMed ID: 1730316 [TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor. Elstad MR; Stafforini DM; McIntyre TM; Prescott SM; Zimmerman GA J Biol Chem; 1989 May; 264(15):8467-70. PubMed ID: 2722780 [TBL] [Abstract][Full Text] [Related]
9. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases. Dulioust A; Hilliquin P; Menkes CJ; Benveniste J; Arnoux B Scand J Rheumatol; 1992; 21(4):161-4. PubMed ID: 1529281 [TBL] [Abstract][Full Text] [Related]
10. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975 [TBL] [Abstract][Full Text] [Related]
11. Serum PAF acetylhydrolase increases during neonatal maturation. Caplan M; Hsueh W; Kelly A; Donovan M Prostaglandins; 1990 Jun; 39(6):705-14. PubMed ID: 2371412 [TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma. Parks JE; Hough SR J Androl; 1993; 14(5):335-9. PubMed ID: 8288488 [TBL] [Abstract][Full Text] [Related]
14. Increased platelet-activating factor-acetylhydrolase activity in the umbilical venous plasma of growth-restricted fetuses. Ohshige A; Yoshimura T; Maeda T; Ito M; Okamura H Obstet Gynecol; 1999 Feb; 93(2):180-3. PubMed ID: 9932551 [TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis. Iatrou C; Moustakas G; Antonopoulou S; Demopoulos CA; Ziroyiannis P Nephron; 1996; 72(4):611-6. PubMed ID: 8730430 [TBL] [Abstract][Full Text] [Related]
16. Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation. Meade CJ; Birke F; Metcalfe S; Watson C; Jamieson N; Neild G J Lipid Mediat Cell Signal; 1994 May; 9(3):205-15. PubMed ID: 7921780 [TBL] [Abstract][Full Text] [Related]
17. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766 [TBL] [Abstract][Full Text] [Related]
18. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers. Imaizumi T; Satoh K; Yoshida H; Kawamura Y; Hiramoto M; Koyanagi M; Takamatsu S; Takamatsu M Heart Vessels; 1990; 5(2):81-6. PubMed ID: 2354992 [TBL] [Abstract][Full Text] [Related]
19. The platelet-activating factor acetylhydrolase of mouse platelets. Karpouza AP; Vakirtzi-Lemonias C Biochim Biophys Acta; 1997 Jan; 1323(1):12-22. PubMed ID: 9030208 [TBL] [Abstract][Full Text] [Related]
20. PAF and hematopoiesis. II. Elevated levels of plasma paf acetylhydrolase after rapid infusion of 5-fluorouracil in cancer patients. Denizot Y; Dupuis F; Roullet B; Praloran V Cancer Lett; 1994 Oct; 85(2):185-8. PubMed ID: 7954335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]